Evidence map›Paper›PMID 21716805›Full record

ArticleMedChemComm2011

Computational ligand-based rational design: Role of conformational sampling and force fields in model development.

Jihyun Shim, Alexander D Mackerell

Abstract read
In one paragraph

Article in MedChemComm, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Open-Sourced In Silico Drug Screening.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. CBPDdb: a curated database of compounds derived from Coumarin-Benzothiazole-Pyrazole.Database : the journal of biological databases and curation · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Structure-based molecular modeling in SAR analysis and lead optimization.Computational and structural biotechnology journal · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Force Fields for Small Molecules.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jihyun ShimHSFII, 20 Penn St. Baltimore, MD 21201, USA. ; Tel: 410 706 7442.
Alexander D Mackerell

Funding

OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITYR01DA013583 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI COOP, ANDREW · 2001 to 2012
$2.5M
Substrate requirements of the bile acid transporterR01DK067530 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI POLLI, JAMES E · 2005 to 2009
$1.4M
Reversing the toxic effects of drugs of abuseK02DA019634 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI COOP, ANDREW · 2005 to 2009
$528k
NIDA NIH HHS K02 DA019634NIDA NIH HHS R01 DA013583NIDDK NIH HHS R01 DK067530
6 · The paper itself

Abstract

A significant number of drug discovery efforts are based on natural products or high throughput screens from which compounds showing potential therapeutic effects are identified without knowledge of the target molecule or its 3D structure. In such cases computational ligand-based drug design (LBDD) can accelerate the drug discovery processes. LBDD is a general approach to elucidate the relationship of a compound's structure and physicochemical attributes to its biological activity. The resulting structure-activity relationship (SAR) may then act as the basis for the prediction of compounds with improved biological attributes. LBDD methods range from pharmacophore models identifying essential features of ligands responsible for their activity, quantitative structure-activity relationships (QSAR) yielding quantitative estimates of activities based on physiochemical properties, and to similarity searching, which explores compounds with similar properties as well as various combinations of the above. A number of recent LBDD approaches involve the use of multiple conformations of the ligands being studied. One of the basic components to generate multiple conformations in LBDD is molecular mechanics (MM), which apply an empirical energy function to relate conformation to energies and forces. The collection of conformations for ligands is then combined with functional data using methods ranging from regression analysis to neural networks, from which the SAR is determined. Accordingly, for effective application of LBDD for SAR determinations it is important that the compounds be accurately modelled such that the appropriate range of conformations accessible to the ligands is identified. Such accurate modelling is largely based on use of the appropriate empirical force field for the molecules being investigated and the approaches used to generate the conformations. The present chapter includes a brief overview of currently used SAR methods in LBDD followed by a more detailed presentation of issues and limitations associated with empirical energy functions and conformational sampling methods.

Identifiers

PMID21716805
PMCPMC3123535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.